Misemer Pharmaceutical, Inc
FDA inspection history in Ripley, Mississippi, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at Ripley, Mississippi.
Cited most
Across all Misemer Pharmaceutical observations on file
- 21 CFR 314.80(b)Postmarketing reporting of adverse drug experiences3
- 21 CFR 314.81(b)(2)Other postmarketing reports1
The complete Misemer Pharmaceutical file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Ripley, Mississippi
One Form 483 · 2026 · 4 observations
Latest: Form 483, Feb 23, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-02-23 | 483 Form 483 | Ripley, Mississippi | 4 | $99 |
Investigators on these documents
FEI number 3016439754 · most recent document Feb 23, 2026
About Misemer Pharmaceutical, Inc
How many FDA Form 483s has Misemer Pharmaceutical, Inc received?
FDA Intel has 1 Form 483 on file for Misemer Pharmaceutical, Inc; the most recent is dated Feb 23, 2026.
When was Misemer Pharmaceutical, Inc last inspected by FDA?
The most recent FDA inspection document on file for Misemer Pharmaceutical, Inc is a Form 483 dated Feb 23, 2026, for the site in Ripley, Mississippi.
What did FDA cite at Misemer Pharmaceutical, Inc?
The regulations cited most in the observations on file for Misemer Pharmaceutical, Inc are 21 CFR 314.80(b) (Postmarketing reporting of adverse drug experiences), 3 times; 21 CFR 314.81(b)(2) (Other postmarketing reports), 1 time.